Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-19-013524
Filing Date
2019-03-12
Accepted
2019-03-12 16:18:27
Documents
1
Group Members
JOSHUA LANDESNELSON OBUSWYNNEFIELD CAPITAL MANAGEMENT, LLCWYNNEFIELD CAPITAL, INC.WYNNEFIELD CAPITAL, INC. PROFIT SHARING PLANWYNNEFIELD PARTNERS SMALL CAP VALUE, L.P.WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND, LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 8 tv515977_sc13da.htm SC 13D/A 155581
  Complete submission text file 0001144204-19-013524.txt   157481
Mailing Address 450 SEVENTH AVENUE SUITE 509 NEW YORK NY 10123
Business Address 450 SEVENTH AVENUE SUITE 509 NEW YORK NY 10123 212-760-0814
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I (Filed by) CIK: 0001251565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Subject) CIK: 0001415684 (see all company filings)

EIN.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85226 | Film No.: 19675280
SIC: 2834 Pharmaceutical Preparations